The impact of dysphagia in myositis: A systematic review and meta-analysis

45Citations
Citations of this article
97Readers
Mendeley users who have this article in their library.

Abstract

(1) Background: Dysphagia is a clinical hallmark and part of the current American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) diagnostic criteria for idiopathic inflammatory myopathy (IIM). However, the data on dysphagia in IIM are heterogenous and partly conflicting. The aim of this study was to conduct a systematic review on epidemiology, pathophysiology, outcome and therapy and a meta-analysis on the prevalence of dysphagia in IIM. (2) Methods: Medline was systematically searched for all relevant articles. A random effect model was chosen to estimate the pooled prevalence of dysphagia in the overall cohort of patients with IIM and in different subgroups. (3) Results: 234 studies were included in the review and 116 (10,382 subjects) in the meta-analysis. Dysphagia can occur as initial or sole symptom. The overall pooled prevalence estimate in IIM was 36% and with 56% particularly high in inclusion body myositis. The prevalence estimate was significantly higher in patients with cancer-associated myositis and with NXP2 autoantibodies. Dysphagia is caused by inflammatory involvement of the swallowing muscles, which can lead to reduced pharyngeal contractility, cricopharyngeal dysfunction, reduced laryngeal elevation and hypomotility of the esophagus. Swallowing disorders not only impair the quality of life but can lead to serious complications such as aspiration pneumonia, thus increasing mortality. Beneficial treatment approaches reported include immunomodulatory therapy, the treatment of associated malignant diseases or interventional procedures targeting the cricopharyngeal muscle such as myotomy, dilatation or botulinum toxin injections. (4) Conclusion: Dysphagia should be included as a therapeutic target, especially in the outlined high-risk groups.

References Powered by Scopus

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

53022Citations
N/AReaders
Get full text

Polymyositis and Dermatomyositis

4239Citations
N/AReaders
Get full text

Assessing bias in studies of prognostic factors

2280Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Neurogenic Dysphagia: Systematic Review and Proposal of a Classification System

64Citations
N/AReaders
Get full text

British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy

62Citations
N/AReaders
Get full text

Comparison of Simultaneous Swallowing Endoscopy and Videofluoroscopy in Neurogenic Dysphagia

41Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Labeit, B., Pawlitzki, M., Ruck, T., Muhle, P., Claus, I., Suntrup-Krueger, S., … Dziewas, R. (2020, July 1). The impact of dysphagia in myositis: A systematic review and meta-analysis. Journal of Clinical Medicine. MDPI. https://doi.org/10.3390/jcm9072150

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 32

80%

Researcher 4

10%

Professor / Associate Prof. 2

5%

Lecturer / Post doc 2

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 35

70%

Nursing and Health Professions 7

14%

Immunology and Microbiology 5

10%

Neuroscience 3

6%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free